PharmiWeb.com - Global Pharma News & Resources
07-Feb-2019

Trinity Dermatology, Now a Part of U.S. Dermatology Partners, Begins Offering Mohs Surgery in Carrollton, Texas

Trinity Dermatology, Now a Part of U.S. Dermatology Partners, Begins Offering Mohs Surgery in Carrollton, Texas U.S. Dermatology Partners announces expanded offerings to include Mohs Surgery to patients in Carrollton and surrounding communities. Services will be available beginning February 5th.

PR Newswire

CARROLLTON, Texas, Feb. 7, 2019

CARROLLTON, Texas, Feb. 7, 2019 /PRNewswire-PRWeb/ -- Trinity Dermatology, now a part of U.S. Dermatology Partners, announces expanded offerings to include Mohs Surgery to patients in Carrollton and surrounding communities. Services will be available beginning February 5th. Trinity Dermatology Carrollton was founded in 1990 and provides medical, surgical, and cosmetic dermatology expertise with five board-certified dermatologists.

The newly renovated offices include four surgery rooms and specialized Mohs equipment. Surgeries will be performed by Howard Steinman, MD, a leading expert in the field of Mohs surgery, specializing in the treatment of basal cell carcinoma, squamous cell carcinoma, and more complicated skin cancer cases.

Dr. Steinman earned his Doctor of Medicine from Washington University School of Medicine in St. Louis, Mo. He completed his dermatology residency at the University of California at San Diego, and his Mohs micrographic surgery and dermatological surgery fellowship at the University of Illinois at Chicago. Dr. Steinman has co-authored two Mohs surgery textbooks as well as 12 textbook chapters. He co-directs an annual course in Mohs surgery and frequently lectures in the United States, Europe, and Australia.

He is passionate about patient care and mentoring fellow physicians. "As a skin cancer surgeon and cancer survivor, I know how important it is for every patient to have an informed, personalized, caring, safe, and comfortable surgical experience," says Dr. Steinman.

Mohs Surgery is the most effective treatment for most types of skin cancer. The Mohs procedure involves surgically removing the cancer layer by layer and examining the tissue under a microscope until healthy, cancer-free tissue around the tumor is reached (commonly referred to as clear margins). Mohs Surgery fellows are trained as a cancer surgeon, pathologist, and reconstructive surgeon. Mohs Surgery has the highest success rate of all treatments for skin cancer – up to 99%.

About U.S. Dermatology Partners
As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners patients not only have access to general medical, surgical, and cosmetic skin treatment through its coordinated care network, but also benefit from the practice's strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com

 

SOURCE U.S. Dermatology Partners

Editor Details

Last Updated: 07-Feb-2019